URL details: www.opdivorx.com/uc

home > domains > opdivorx.com > www.opdivorx.com/uc

URL title: Adjuvant OPDIVO® (nivolumab) for Certain Patients With Urothelial Carcinoma
URL description: OPDIVO® (nivolumab) is the only now FDA-approved option for high-risk patients with UC at high risk of recurrence after radical resection, regardless of prior neoadjuvant chemotherapy, nodal involvement, or PD-L1 status. Please see Indication and Important Safety Information.
URL last crawled: 2022-09-18
URL speed: 0.339 MB/s, downloaded in 0.400 seconds

open external url

3 external links to this url

Only links from external domains are shown on this page.